comparemela.com

Page 14 - Apogee Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biotech workforce continued to expand in Mass last year, report says

BiondVax Pharmaceuticals Ltd Rebrands as Scinai Immunotherapeutics Ltd to Reflect New Focus on Development of Novel Inflammation and Immunology (I&I) Biological Therapeutics

BiondVax Pharmaceuticals Ltd Rebrands as Scinai Immunotherapeutics Ltd to Reflect New Focus on Development of Novel Inflammation and Immunology (I&I) Biological Therapeutics
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Star Therapeutics adds another $90M to grow its galaxy of drug startups

Apogee Therapeutics (NASDAQ:APGE) Stock Rating Reaffirmed by William Blair

Apogee Therapeutics (NASDAQ:APGE – Get Free Report)‘s stock had its “outperform” rating restated by equities research analysts at William Blair in a report released on Monday, RTT News reports. They presently have a $40.00 price objective on the stock. William Blair’s target price suggests a potential upside of 70.21% from the stock’s previous close. A […]

Apogee Therapeutics (NASDAQ:APGE) Releases Earnings Results, Misses Expectations By $1 29 EPS

Apogee Therapeutics (NASDAQ:APGE – Get Free Report) announced its quarterly earnings results on Monday. The company reported ($3.78) EPS for the quarter, missing analysts’ consensus estimates of ($2.49) by ($1.29), MarketWatch Earnings reports. Apogee Therapeutics Price Performance APGE opened at $23.50 on Wednesday. Apogee Therapeutics has a 1-year low of $19.98 and a 1-year high […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.